Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Sponsor: AbbVie
Check if you qualify for this ovarian cancer clinical trial in Irvine, CA
If you're searching for ovarian cancer treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.